Publications Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor Wang et al. 30 June 2025 Link To Article Previous article: Discovery of ZN-c5, an Orally Bioavailable Selective Estrogen 2 Receptor Degrader (SERD) with Improved Pharmacokinetics Prev Next article: Structure-based Design of Pyridone−Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition Next
